CoChat

Toward an Understanding of Changes in Diversity Associated with Fecal Microbiome Transplantation Based on 16S rRNA Gene Deep Sequencing

Open access
Shahinas, Dea, Silverman, Michael, Sittler, Taylor, Chiu, Charles, Kim, Peter, Allen-Vercoe, Emma, Weese, Scott, Wong, Andrew, Low, Donald E., Pillai, Dylan R. · 2012 · mBio

The DOI matches its Crossref record; 52 of the 53 references it cites were found in a registry or an index, and 1 are not checked yet.

Abstract

Fecal microbiome transplantation by low-volume enema is an effective, safe, and inexpensive alternative to antibiotic therapy for patients with chronic relapsing Clostridium difficile infection (CDI). We explored the microbial diversity of pre- and posttransplant stool specimens from CDI patients (n = 6) using deep sequencing of the 16S rRNA gene. While interindividual variability in microbiota change occurs with fecal transplantation and vancomycin exposure, in this pilot study we note that clinical cure of CDI is associated with an increase in diversity and richness. Genus- and species-level analysis may reveal a cocktail of microorganisms or products thereof that will ultimately be used as a probiotic to treat CDI. IMPORTANCE Antibiotic-associated diarrhea (AAD) due to Clostridium difficile is a widespread phenomenon in hospitals today. Despite the use of antibiotics, up to 30% of patients are unable to clear the infection and suffer recurrent bouts of diarrheal disease. As a result, clinicians have resorted to fecal microbiome transplantation (FT). Donor stool for this type of therapy is typically obtained from a spouse or close relative and thoroughly tested for various pathogenic microorganisms prior to infusion. Anecdotal reports suggest a very high success rate of FT in patients who fail antibiotic treatment (>90%). We used deep-sequencing technology to explore the human microbial diversity in patients with Clostridium difficile infection (CDI) disease after FT. Genus- and species-level analysis revealed a cocktail of microorganisms in the Bacteroidetes and Firmicutes phyla that may ultimately be used as a probiotic to treat CDI.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1128/mbio.00338-12

Cites

52 of 53 references verified0 citation errors · 0 not checkable

Statistics

Figures

FIG 1 Rank abundance curve comparison of refOTUs for all donors and recipients pre- and post-FT. Abundance has been shown in log scale on the y axis, and the rank order of the refOTUs is shown on the x axis. The dashed blue line corresponds (99% detection) to an abundance of 5. Summary statistics are tabulated in Table S1 in the supplemental material. D#-S, donor of successful transplant; D#-F, donor of failed transplant; R# Pre, recipient pre-FT; R# Post-S, recipient post-successful FT.
FIG 1 Rank abundance curve comparison of refOTUs for all donors and recipients pre- and post-FT. Abundance has been shown in log scale on the y axis, and the rank order of the refOTUs is shown on the x axis. The dashed blue line corresponds (99% detection) to an abundance of 5. Summary statistics are tabulated in Table S1 in the supplemental material. D#-S, donor of successful transplant; D#-F, donor of failed transplant; R# Pre, recipient pre-FT; R# Post-S, recipient post-successful FT.CC BY-NC-SA · PubMed Central
FIG 2 Rarefaction curve comparison of refOTUs for all donors and recipients pre- and post-FT. Phylogenetic diversity is plotted against the number of V5-V6 sequence reads for each donor and recipient pre- and post-FT. D-S, donor of successful transplant; D-F, donor of failed transplant; R Pre, recipient pre-FT; R Post-S, recipient post-successful FT; R Post-F, recipient post-failed FT. Each 30th point was plotted with the confidence interval at 95%.
FIG 2 Rarefaction curve comparison of refOTUs for all donors and recipients pre- and post-FT. Phylogenetic diversity is plotted against the number of V5-V6 sequence reads for each donor and recipient pre- and post-FT. D-S, donor of successful transplant; D-F, donor of failed transplant; R Pre, recipient pre-FT; R Post-S, recipient post-successful FT; R Post-F, recipient post-failed FT. Each 30th point was plotted with the confidence interval at 95%.CC BY-NC-SA · PubMed Central
FIG 3 Diversity statistics observed for all donors and recipients pre- and post-FT. Observed taxon richness, Shannon diversity, and Simpson diversity for each sample are shown. The lines in the plots represent the medians for each group. The asterisks denote the failed-FT samples. R Pre samples are characterized by fewer taxa and lower diversity than those of post-FT and donor samples. R Pre, recipient pre-FT samples; R Post, recipient post-FT samples; D, donor samples.
FIG 3 Diversity statistics observed for all donors and recipients pre- and post-FT. Observed taxon richness, Shannon diversity, and Simpson diversity for each sample are shown. The lines in the plots represent the medians for each group. The asterisks denote the failed-FT samples. R Pre samples are characterized by fewer taxa and lower diversity than those of post-FT and donor samples. R Pre, recipient pre-FT samples; R Post, recipient post-FT samples; D, donor samples.CC BY-NC-SA · PubMed Central
FIG 4 (A) PCoA. PCoA represents multivariate analysis, which explores community similarity by measuring phylogenetic branch length (UniFrac) of 16S rRNA tag sequences. The dots represent the projected shadows of the samples on the respective two-dimensional planes (xy, blue; yz, red; xz, green). The x axis, y axis, and z axis represent 27.1%, 24.0%, and 20.7% of the intersample variability, respectively. R Pre, recipient pre-FT; R Post-F, recipient post-failed FT; D-S, donor of successful transplant; R Post-S, recipient post-successful FT; D-F, donor of failed transplant. (B) PCoA axes in relation to observed variability. The percentage of variability observed is depicted in relation to the first five axes. The dashed line at 5.26% represents the amount of variability expected for each axis based on random events.
FIG 4 (A) PCoA. PCoA represents multivariate analysis, which explores community similarity by measuring phylogenetic branch length (UniFrac) of 16S rRNA tag sequences. The dots represent the projected shadows of the samples on the respective two-dimensional planes (xy, blue; yz, red; xz, green). The x axis, y axis, and z axis represent 27.1%, 24.0%, and 20.7% of the intersample variability, respectively. R Pre, recipient pre-FT; R Post-F, recipient post-failed FT; D-S, donor of successful transplant; R Post-S, recipient post-successful FT; D-F, donor of failed transplant. (B) PCoA axes in relation to observed variability. The percentage of variability observed is depicted in relation to the first five axes. The dashed line at 5.26% represents the amount of variability expected for each axis based on random events.CC BY-NC-SA · PubMed Central
FIG 5 Phylum-level differences for each FT set. Donor (D) and post-successful (Post-S)-FT microbial populations are distinctive from pre-FT (R Pre) and post-failed (Post-F)-FT samples by higher levels of Bacteroidetes and Firmicutes and lower levels of Proteobacteria. At the phylum level, there is no difference observed between the failed-FT donor samples and the successful-FT donor samples.
FIG 5 Phylum-level differences for each FT set. Donor (D) and post-successful (Post-S)-FT microbial populations are distinctive from pre-FT (R Pre) and post-failed (Post-F)-FT samples by higher levels of Bacteroidetes and Firmicutes and lower levels of Proteobacteria. At the phylum level, there is no difference observed between the failed-FT donor samples and the successful-FT donor samples.CC BY-NC-SA · PubMed Central
FIG 6 (A) Comparison of refOTU structures across the stool microbial communities. The Venn diagram displays the overlapping refOTUs for pooled samples belonging to each sample type. Each of the communities is characterized by more unique than overlapping refOTUs. The highest overlap is seen between R Pre and R Post-F samples as well as between R Post-S and D-S samples. R Pre, recipient pre-FT samples; R Post, recipient post-FT samples; D-S, donor samples. (B) Relative contributions of significant genera in pooled specimens before and after FT. Genera shown as a percentage of the total genera for each sample type are depicted. Only genera which change significantly (P < 0.05, EDGE analysis) following FT are depicted. R Pre, recipient pre-FT samples; R Post-S, recipient post-FT samples; D-S, donor samples. (C) Relative percentage of species in pooled specimens before and after FT. Species which increased significantly (P < 0.05, EDGE analysis) following FT are shown as absolute counts (number of V5-V6 sequence reads) for each sample type. R Pre, recipient pre-FT samples; R Post, recipient post-FT samples; D, donor samples.
FIG 6 (A) Comparison of refOTU structures across the stool microbial communities. The Venn diagram displays the overlapping refOTUs for pooled samples belonging to each sample type. Each of the communities is characterized by more unique than overlapping refOTUs. The highest overlap is seen between R Pre and R Post-F samples as well as between R Post-S and D-S samples. R Pre, recipient pre-FT samples; R Post, recipient post-FT samples; D-S, donor samples. (B) Relative contributions of significant genera in pooled specimens before and after FT. Genera shown as a percentage of the total genera for each sample type are depicted. Only genera which change significantly (P < 0.05, EDGE analysis) following FT are depicted. R Pre, recipient pre-FT samples; R Post-S, recipient post-FT samples; D-S, donor samples. (C) Relative percentage of species in pooled specimens before and after FT. Species which increased significantly (P < 0.05, EDGE analysis) following FT are shown as absolute counts (number of V5-V6 sequence reads) for each sample type. R Pre, recipient pre-FT samples; R Post, recipient post-FT samples; D, donor samples.CC BY-NC-SA · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 53 references

Cited by

See all 191

Metadata

Authors
Shahinas, D., Silverman, M., Sittler, T., Chiu, C., Kim, P., Allen-Vercoe, E., Weese, S., Wong, A., Low, D. E., & Pillai, D. R.
Affiliations
  • University of Toronto (CA)
  • Lakeridge Health (CA)
  • University of California, San Francisco (US)
  • University of Guelph (CA)
  • Department of Molecular and Cell Biology, University of Guelph, Guelph, Ontario, Canada
  • Department of Pathobiology, Ontario Veterinary College, University of Guelph, Guelph, Ontario, Canada
  • Queen's University (CA)
  • Mount Sinai Hospital (CA)
  • University of Calgary (CA)
Venue
mBio
Published
2012-11
Volume
3
Issue
5
ISSN
  • 2150-7511 (ISSN-L)
  • 2161-2129
OpenAlex
W2148389200
Cited by
191
References
52
Citations by year
2026: 2 · 2025: 7 · 2024: 7 · 2023: 5 · 2022: 11 · 2021: 10 · 2020: 13 · 2019: 12 · 2018: 17 · 2017: 17 · 2016: 25 · 2015: 18 · 2014: 22 · 2013: 24 · 2012: 1
FWCI
14.35
Type
journal article
Language
en
Open access
Licence
Locations
  • mBio (publishedVersion, cc-by-nc-sa)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-sa)
  • PubMed Central (publishedVersion, cc-by-nc-sa)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
University of Michigan
Topics
  • Health Sciences › Medicine › Infectious Diseases › Clostridium difficile and Clostridium perfringens research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
  • Health Sciences › Medicine › Microbiology (medical) › Bacterial Identification and Susceptibility Testing
Keywords
Clostridium difficile infection, microbial diversity, 16S rRNA gene sequencing, vancomycin, antibiotic-associated diarrhea, probiotics, Bacteroidetes, Firmicutes, interindividual variability
MeSH terms
Clostridium Infections, Feces, Humans, Clostridioides difficile, Genes, rRNA, Metagenome, High-Throughput Nucleotide Sequencing

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Toward an Understanding of Changes in Diversity Associated with Fecal Microbiome Transplantation Based on 16S rRNA Gene Deep Sequencing. https://app.cochat.ai/papers/10.1128/mbio.00338-12
The paper
Shahinas, D., Silverman, M., Sittler, T., Chiu, C., Kim, P., Allen-Vercoe, E., Weese, S., Wong, A., Low, D. E., & Pillai, D. R. (2012). Toward an Understanding of Changes in Diversity Associated with Fecal Microbiome Transplantation Based on 16S rRNA Gene Deep Sequencing. mBio. https://doi.org/10.1128/mbio.00338-12

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.